After being fired, I became the light of medicine

Chapter 29 Avatrombopag Abroad—Price Reduction!
The news that Tsingshan Pharmaceutical's "ITG Human Myelopoietin" was about to start clinical trials soon appeared on the website of the State Food and Drug Administration, and the major domestic pharmaceutical companies were the first to notice it.

Major pharmaceutical companies were shocked, until they saw that this was just an auxiliary treatment drug, and then they breathed a sigh of relief.

That is, it would be terrible if every drug was a first-line drug.

What are first-line drugs? What are adjuvant drugs?

simply put,
For example, if you are accidentally infected with influenza A one day, the doctor will generally recommend that you take "oseltamivir" and other medicines, such as Lianhua Qingwen and antiviral granules, for combined treatment.

Oseltamivir is a specific drug used to treat influenza A, and it is the first-line drug.

As for medicines such as Lianhua Qingwen and antiviral granules, even if you replace them with vitamin C or isatis root, it will not affect the treatment effect much. These are auxiliary medicines.

Therefore, auxiliary drugs are highly substitutable and their competitiveness is far inferior to that of first-line drugs!
Many pharmaceutical companies were completely relieved, as it was just an auxiliary drug for the treatment of aplastic anemia and there was nothing to worry about.

In the following week, "ITG human myelopoietin" did not make much progress, just as Feng Gang had said. Due to the lack of attractiveness of the treatment, even the first batch of 15 patients had not been recruited after a week.

Zhang Yang was not in a hurry.

Firstly, this was something he had expected, and secondly, at this time all his energy was focused on the Phase III clinical trial of Qingshan Avatrombopag.

……

Compared with the slow clinical recruitment of "ITG human ovulation hormone", "Qingshan Avatrombopag Tablets" can be said to be extremely smooth.

In addition to the 465 subjects recruited in the first month, the efficiency continued unabated in the following two weeks, and the remaining 200-plus places were quickly snapped up by chemotherapy patients, liver disease patients, and others who came to the hospital.

On the 46th day of recruitment, with the successful enrollment of the last trial group, the Phase III clinical recruitment of "Qingshan Avatrombopag" was officially completed.

Zhang Yang immediately announced the news to the public.

When the news came out, the entire pharmaceutical industry was quite surprised.

You know, why does the Phase III clinical trial of an innovative drug often take 3-5 years?
This is because in addition to the need to constantly adjust the drug composition during the clinical process, it also takes a very long time to recruit patients.

Normally, it would be good enough to complete the experiment with 700 people within one year, but now!
46 days?
Domestic pharmaceutical companies were shocked, but they had to admit that this was indeed because the Qingshan Avatrombopag Tablets were so effective, and only in this way could they attract so many patients to join crazily.

While everyone was still immersed in surprise, just a few days later, a sudden news appeared on the Chinese Internet.

After entering the Chinese market for three years, the price of Avatrombopag Tablets, developed by the American company AkaRx, has been reduced.

On JD Pharmacy, the price of AkaRx's "Avatrombopag Tablets" has dropped from 7800 yuan per box to 6900 yuan per box, a reduction of 900 yuan.

The news spread quickly, and the first people to notice it were cancer patients who needed to take Avatrombopag tablets for a long time.

Compared with the traditional treatment options for blood patients, there is also the previous generation of thrombopoietin, "Eltrombopag", which can be used.

Cancer patients, especially those undergoing long-term chemotherapy, have very limited options.

Chemotherapy, in addition to killing cancer cells, also kills a large number of other normal cells in the human body.

Therefore, almost all chemotherapy patients will suffer from hair loss and "low platelet disease".

In order for the body to continue to meet the standards of chemotherapy, multiple indicators such as platelets need to be rapidly increased during chemotherapy.

Traditional drugs that increase platelets are too slow to take effect. Eltrombopag has serious side effects on liver and kidney function, and chemotherapy patients can hardly bear it. The only option is Avatrombopag tablets, which have almost no side effects and a very good therapeutic effect.

In the Magic City, in a cancer hospital ward.

"Oh, good news, good news, Brother Zhou and Lao Yang, come and have a look, the price of 'Avatrombopag' has dropped!"

The speaker is Xiao Qiang, 30 years old, a patient with stage 3 lung cancer, who has been undergoing chemotherapy for more than three months.

The Brother Zhou and Lao Yang he called were also lung cancer patients.

"It's dropped? Xiao Xiao, don't be ridiculous. I just bought a box yesterday morning, and it was still 7800. Why is it dropping?"

The one who spoke was Lao Yang.

At this time, Brother Zhou on the side also said:
"Xiao Xiao, Avatrombopag has been in China for two or three years. When have you ever seen its price drop? Not to mention a price drop, the drugstore was out of stock last month. I'm grateful that it didn't raise the price!"

"Hey! If you don't believe me, come and see for yourself. It's really dropped! JD Pharmacy has dropped it to 6900!" "Really dropped it?"

After listening to Xiao Qiang's confident words, Brother Zhou and Lao Yang came over half-believingly. When they took a look, they were immediately filled with surprise!

"Fuck, the price actually dropped!"

"Yes, this is the first time in the world. Could it be that he has a change of heart?"

"A change of heart?"

Xiao Qiang couldn't help but smile bitterly:
"Brother Zhou, do you believe him or do you believe me as Qin Shi Huang? How could this group of pharmaceutical companies have a change of heart?"

"Forget about this drug. When have you ever seen the price of any foreign targeted drug or imported drug drop?"

The two of them nodded.

"Then why did the price suddenly drop?"

At this moment, the three people's eyes fell on the press release on their phones at the same time.

After a while, the three of them raised their heads, with some disbelief in their eyes.

"I remember this Qingshan Pharmaceutical. Their 'Qingshan Avatrombopag' caused a lot of controversy some time ago. I didn't expect that they really put pressure on foreign pharmaceutical companies!"

Brother Zhou couldn't help but take a deep breath, his face full of solemnity!
"Old Yang, you said before that domestically produced medicines would not be very effective. Now it seems that we have to thank Qingshan Pharmaceutical!"

"If nothing else, this 900 yuan price reduction is what they saved us!"

Old Yang nodded heavily and murmured:

"Qingshan Pharmaceutical!"

The news not only spread in the oncology ward, but also quickly spread to the blood disease patient groups and liver disease patient groups. All patients knew the answer in their hearts.

The price reduction is not because foreign pharmaceutical companies have a change of heart, but because they feel the pressure.

The source of the pressure is Qingshan Pharmaceutical and its "Qingshan Avatrombopag Tablets".

……

It's 5:30 in the afternoon and it's time to get off work.

In the hematology doctor's office of the Third People's Hospital of Chengdu, Director Hu looked at the screen of his mobile phone and couldn't help but smile.

After a while, another deputy chief physician, Ren Xiaoyang, walked into the office.

Director Hu called out to Ren Xiaoyang.

"Professor Ren, let's have a drink together after get off work."

Ren Xiaoyang was filled with surprise and was completely confused.

"Director, don't you usually not drink?"

Director Hu smiled slightly, then pointed to the phone screen:
“Just read the news.”

"I'm so happy today, I'm making an exception!"

"Happy?"

Ren Xiaoyang quickly glanced at his phone, and what caught his eye was a huge headline.

【AkaRx's "Avatrombopag Tablets" encountered pressure from domestic new drugs and reduced its price in China for the first time. 】

He was stunned for two seconds, and suddenly a surge of excitement rushed to his head.

"Director, I'll accompany you!"

(End of this chapter)